Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3629585
Max Phase: Preclinical
Molecular Formula: C24H13BrF5NO5S2
Molecular Weight: 634.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3629585
Max Phase: Preclinical
Molecular Formula: C24H13BrF5NO5S2
Molecular Weight: 634.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccc(-c2cccc(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)c2)s1)c1c(F)ccc(O)c1F
Standard InChI: InChI=1S/C24H13BrF5NO5S2/c25-13-4-9-20(17(11-13)36-24(28,29)30)38(34,35)31-14-3-1-2-12(10-14)18-7-8-19(37-18)23(33)21-15(26)5-6-16(32)22(21)27/h1-11,31-32H
Standard InChI Key: FUEBVUVFPJRPIE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 634.40 | Molecular Weight (Monoisotopic): 632.9339 | AlogP: 7.09 | #Rotatable Bonds: 7 |
Polar Surface Area: 92.70 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.81 | CX Basic pKa: | CX LogP: 7.66 | CX LogD: 6.99 |
Aromatic Rings: 4 | Heavy Atoms: 38 | QED Weighted: 0.17 | Np Likeness Score: -1.32 |
1. Abdelsamie AS, Bey E, Gargano EM, van Koppen CJ, Empting M, Frotscher M.. (2015) Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme., 103 [PMID:26322835] [10.1016/j.ejmech.2015.08.030] |
Source(1):